SIS Ventures

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, established in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm specializes in developing advanced diagnostics for the early detection of various cancers, focusing on Stage I and Stage II malignancies where timely intervention can significantly improve patient outcomes. Utilizing a combination of infrared spectroscopy and artificial intelligence, Dxcover's technology enables the detection of cancer from a simple blood sample, allowing for same-day diagnosis and patient stratification. This innovative approach aims to enhance treatment options and ultimately improve survival rates and quality of life for patients.

MiAlgae Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the production of microalgal products aimed at replacing fishmeal in livestock feeds. The company focuses on generating high-value microalgae rich in Omega-3 fatty acids and antioxidants, essential for the nutrition of livestock, particularly in the aquaculture sector. By utilizing wastewater remediation in its production processes, MiAlgae embraces a circular economy model that reduces operating costs and enhances competitiveness against traditional feed supplements. The company's innovative approach not only addresses the nutritional needs of livestock and pets but also promotes sustainable practices in the agriculture industry.

Solasta Bio focuses on developing environmentally friendly products that address the global demand for innovative and effective crop protection. The company creates biological pesticides and neuropeptide-based insect control solutions designed to provide superior natural protection for crops. Its product portfolio encompasses a wide range of offerings that target various pests, including those that have developed resistance to traditional synthetic chemicals. By enabling farmers to manage pest populations sustainably, Solasta Bio aims to enhance crop production while prioritizing safety and environmental responsibility.

Metacarpal is a pioneering company specializing in the development of body-powered bionic prosthetic hands, designed to enhance the lives of individuals with limb differences. The company's innovative technology features variable grips that allow users to switch between different operations, providing the ability to intuitively adjust to various object shapes. This ensures a steady grip through an integrated grip lock mechanism. Metacarpal aims to offer enhanced responsiveness and precision in control, closely resembling the natural movements familiar to users. In addition to their advancements in prosthetic technology, the company is committed to addressing the needs of underserved populations in developing regions, aspiring to make their life-changing products accessible to those in most need.

Nami Surgical specializes in developing and providing advanced robotic surgery technology. Their core offering is ultrasonic surgical tools designed to enhance the current robotic-assisted surgery market. By simplifying and making procedures safer, they expand the use of robots in surgeries requiring ultrasonic devices, thereby improving clinical outcomes and patient care. Their solutions provide surgeons with intuitive, high-performance, and maneuverable instruments for complex surgical tasks.

Nebu-Flow is a manufacturer focused on the development of advanced inhaled drugs aimed at patients with respiratory disorders. The company specializes in innovative pulmonary drug-delivery technology that allows for efficient administration of difficult-to-nebulize medications directly to the lungs. This includes existing formulations as well as emerging therapeutics such as biologics, nanomedicines, and vaccines. Nebu-Flow's technology is designed to control droplet size for optimal deep lung deposition, facilitating injection-free systemic drug delivery through inhalation. The company is dedicated to minimizing its environmental impact while ensuring the creation of a user-friendly and high-performing nebulizer for effective treatment of respiratory diseases.

Carcinotech is a pioneering company in cancer research, specializing in the manufacturing of 3D-printed micro-tumors derived from patient biopsies, primary cells, immune cells, and cancer stem cells. The company aims to enhance the drug screening process and facilitate pre-clinical and personalized medicine testing, ultimately accelerating the delivery of more effective cancer treatments to market. By employing advanced techniques in tissue engineering, robotic manufacturing, and stringent quality control, Carcinotech produces highly predictive, assay-ready printed tumors that reflect the heterogeneity of individual cancers. This innovative approach provides clinicians with models of "clinical biopsy" quality, significantly improving the accuracy of cancer treatment assessments. Collaborating with global partners, including leading pharmaceutical companies and medical professionals, Carcinotech is committed to transforming oncology drug development and increasing the likelihood of successful outcomes for cancer patients.

Trojan Energy Limited is a UK-based company that specializes in providing innovative charging infrastructure solutions for electric vehicles. Incorporated in 2016 and located in Stonehaven, Trojan Energy focuses on the development and deployment of on-street flat and flush electric vehicle charging points. This initiative addresses the challenges faced by vehicle owners who lack access to off-street parking, enabling them to conveniently charge their vehicles wherever parking is available. By offering a practical and accessible charging system, Trojan Energy aims to enhance the user experience for electric vehicle drivers and support the broader adoption of electric mobility.

Beta Bugs is an insect genetics company specializing in the development and distribution of high-performance Black Soldier Fly breeds aimed at enhancing productivity in the insect protein sector. The company operates a breeding program called HiPer-Fly® and maintains a dedicated egg production site known as The Multiplier®, supplying its breeds to both UK and international markets. By focusing on biotechnology and breeding techniques, Beta Bugs aims to create a sustainable protein source that can effectively replace traditional feed ingredients such as fishmeal and soymeal in livestock, aquaculture, and pet feed. Headquartered at the Easter Bush Campus, a recognized center for animal genetics, Beta Bugs collaborates closely with the Roslin Institute, noted for its pioneering work in animal genetics.

Microplate Dx is a developer of innovative diagnostic technology aimed at addressing the critical global health issue of antimicrobial resistance, which leads to drug-resistant infections. Originating as a spinout from the University of Strathclyde in Glasgow, the company focuses on creating solutions that significantly reduce fatalities associated with these infections. Its core technology utilizes highly sensitive biosensor electrodes paired with miniaturized hydrogel deposits containing antibiotics specifically designed for the infections being tested. This approach offers a low-cost, accurate point-of-care diagnostic device that enables timely and optimal antibiotic prescribing, allowing healthcare providers to deliver effective treatments in under one hour. Microplate Dx's mission is to enhance antibiotic stewardship and proactively combat the rise of antimicrobial resistance worldwide.

Manus Neurodynamica Ltd is a company based in North Shields, United Kingdom, established in 2008. It specializes in the development of medical diagnostic technologies aimed at identifying and monitoring neuromotor impairments, particularly focusing on Parkinson’s disease. The company’s innovative device serves as a triage tool that facilitates early diagnosis by analyzing minute limb and hand movements to quantify fine motor skills. This technology, coupled with advanced analytical software, enables clinicians to effectively assess patient movement parameters, thereby enhancing the accuracy of diagnoses and improving the efficiency of neuromotor services. Manus Neurodynamica's solutions are utilized in various settings, including academic research and pharmaceutical studies, as well as in non-medical applications.

Solasta Bio focuses on developing environmentally friendly products that address the global demand for innovative and effective crop protection. The company creates biological pesticides and neuropeptide-based insect control solutions designed to provide superior natural protection for crops. Its product portfolio encompasses a wide range of offerings that target various pests, including those that have developed resistance to traditional synthetic chemicals. By enabling farmers to manage pest populations sustainably, Solasta Bio aims to enhance crop production while prioritizing safety and environmental responsibility.

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, established in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm specializes in developing advanced diagnostics for the early detection of various cancers, focusing on Stage I and Stage II malignancies where timely intervention can significantly improve patient outcomes. Utilizing a combination of infrared spectroscopy and artificial intelligence, Dxcover's technology enables the detection of cancer from a simple blood sample, allowing for same-day diagnosis and patient stratification. This innovative approach aims to enhance treatment options and ultimately improve survival rates and quality of life for patients.

MiAlgae Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the production of microalgal products aimed at replacing fishmeal in livestock feeds. The company focuses on generating high-value microalgae rich in Omega-3 fatty acids and antioxidants, essential for the nutrition of livestock, particularly in the aquaculture sector. By utilizing wastewater remediation in its production processes, MiAlgae embraces a circular economy model that reduces operating costs and enhances competitiveness against traditional feed supplements. The company's innovative approach not only addresses the nutritional needs of livestock and pets but also promotes sustainable practices in the agriculture industry.

Nebu-Flow is a manufacturer focused on the development of advanced inhaled drugs aimed at patients with respiratory disorders. The company specializes in innovative pulmonary drug-delivery technology that allows for efficient administration of difficult-to-nebulize medications directly to the lungs. This includes existing formulations as well as emerging therapeutics such as biologics, nanomedicines, and vaccines. Nebu-Flow's technology is designed to control droplet size for optimal deep lung deposition, facilitating injection-free systemic drug delivery through inhalation. The company is dedicated to minimizing its environmental impact while ensuring the creation of a user-friendly and high-performing nebulizer for effective treatment of respiratory diseases.

Carcinotech is a pioneering company in cancer research, specializing in the manufacturing of 3D-printed micro-tumors derived from patient biopsies, primary cells, immune cells, and cancer stem cells. The company aims to enhance the drug screening process and facilitate pre-clinical and personalized medicine testing, ultimately accelerating the delivery of more effective cancer treatments to market. By employing advanced techniques in tissue engineering, robotic manufacturing, and stringent quality control, Carcinotech produces highly predictive, assay-ready printed tumors that reflect the heterogeneity of individual cancers. This innovative approach provides clinicians with models of "clinical biopsy" quality, significantly improving the accuracy of cancer treatment assessments. Collaborating with global partners, including leading pharmaceutical companies and medical professionals, Carcinotech is committed to transforming oncology drug development and increasing the likelihood of successful outcomes for cancer patients.

Good-Loop is an advertising platform that transforms advertising revenue into funding for social causes, enhancing both the effectiveness and ethics of online advertising. The company distributes video ads through a network of reputable online publishers, allowing users to engage with advertisements voluntarily. When viewers opt to watch an ad, fifty percent of the revenue generated goes directly to a charity of their choice, creating a rewarding experience for consumers. Good-Loop's approach not only fosters social good but also benefits advertisers, as evidenced by their higher engagement rates—61% completed views compared to the industry average of 30%. This dual focus on charitable impact and advertising effectiveness positions Good-Loop as a unique player in the digital advertising landscape.

Talking Medicines Limited is a data technology company based in Glasgow, United Kingdom, that focuses on capturing and structuring the global voice of patients regarding launched medicines. The company offers Medsmart, an application that collects comprehensive data about medication adherence, including how, why, and what patients are taking. Its services include PatientMetRx®, a social intelligence platform that employs artificial intelligence and natural language processing to transform unstructured feedback from patients into actionable insights for pharmaceutical companies. This platform allows clients to utilize large language models to access curated patient and healthcare professional experiences, thereby enabling data-driven decision-making. Talking Medicines also provides a real-world persona data service with monthly updates, digital focus groups for surveys and questionnaires, and custom solutions tailored to specific pharmaceutical needs. Established in 2013 and rebranded in December 2015, the company serves the pharmaceutical and healthcare sectors, aiming to enhance marketing effectiveness and improve patient health outcomes through advanced patient insights.

Trojan Energy Limited is a UK-based company that specializes in providing innovative charging infrastructure solutions for electric vehicles. Incorporated in 2016 and located in Stonehaven, Trojan Energy focuses on the development and deployment of on-street flat and flush electric vehicle charging points. This initiative addresses the challenges faced by vehicle owners who lack access to off-street parking, enabling them to conveniently charge their vehicles wherever parking is available. By offering a practical and accessible charging system, Trojan Energy aims to enhance the user experience for electric vehicle drivers and support the broader adoption of electric mobility.

EnteroBiotix Limited is a biotechnology company based in Edinburgh, United Kingdom, founded in 2017. It specializes in the research, development, and commercialization of orally available products for fecal microbiota transplantation. By utilizing bacterial communities derived from the human gastrointestinal tract, EnteroBiotix aims to restore health and prevent bacterial infections. The company focuses on creating microbial therapeutics, both allogenic and autologous, designed to address serious unmet medical needs. Its product pipeline includes high-diversity microbiome-modulating drugs tailored to fortify and restore the microbiome, enabling physicians to effectively prevent and treat various debilitating infections and diseases.

Trojan Energy Limited is a UK-based company that specializes in providing innovative charging infrastructure solutions for electric vehicles. Incorporated in 2016 and located in Stonehaven, Trojan Energy focuses on the development and deployment of on-street flat and flush electric vehicle charging points. This initiative addresses the challenges faced by vehicle owners who lack access to off-street parking, enabling them to conveniently charge their vehicles wherever parking is available. By offering a practical and accessible charging system, Trojan Energy aims to enhance the user experience for electric vehicle drivers and support the broader adoption of electric mobility.

Solasta Bio focuses on developing environmentally friendly products that address the global demand for innovative and effective crop protection. The company creates biological pesticides and neuropeptide-based insect control solutions designed to provide superior natural protection for crops. Its product portfolio encompasses a wide range of offerings that target various pests, including those that have developed resistance to traditional synthetic chemicals. By enabling farmers to manage pest populations sustainably, Solasta Bio aims to enhance crop production while prioritizing safety and environmental responsibility.

Cyan Forensics specializes in developing advanced technologies aimed at assisting law enforcement agencies, social media platforms, and cloud service providers. Their solutions are designed to detect and prevent the dissemination of harmful content, including material related to paedophilia and terrorism. The company's innovations significantly reduce the time required for police to examine consumer devices, thereby enhancing the efficiency of investigations.

Manus Neurodynamica Ltd is a company based in North Shields, United Kingdom, established in 2008. It specializes in the development of medical diagnostic technologies aimed at identifying and monitoring neuromotor impairments, particularly focusing on Parkinson’s disease. The company’s innovative device serves as a triage tool that facilitates early diagnosis by analyzing minute limb and hand movements to quantify fine motor skills. This technology, coupled with advanced analytical software, enables clinicians to effectively assess patient movement parameters, thereby enhancing the accuracy of diagnoses and improving the efficiency of neuromotor services. Manus Neurodynamica's solutions are utilized in various settings, including academic research and pharmaceutical studies, as well as in non-medical applications.

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, established in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm specializes in developing advanced diagnostics for the early detection of various cancers, focusing on Stage I and Stage II malignancies where timely intervention can significantly improve patient outcomes. Utilizing a combination of infrared spectroscopy and artificial intelligence, Dxcover's technology enables the detection of cancer from a simple blood sample, allowing for same-day diagnosis and patient stratification. This innovative approach aims to enhance treatment options and ultimately improve survival rates and quality of life for patients.

Trojan Energy Limited is a UK-based company that specializes in providing innovative charging infrastructure solutions for electric vehicles. Incorporated in 2016 and located in Stonehaven, Trojan Energy focuses on the development and deployment of on-street flat and flush electric vehicle charging points. This initiative addresses the challenges faced by vehicle owners who lack access to off-street parking, enabling them to conveniently charge their vehicles wherever parking is available. By offering a practical and accessible charging system, Trojan Energy aims to enhance the user experience for electric vehicle drivers and support the broader adoption of electric mobility.

Cyan Forensics specializes in developing advanced technologies aimed at assisting law enforcement agencies, social media platforms, and cloud service providers. Their solutions are designed to detect and prevent the dissemination of harmful content, including material related to paedophilia and terrorism. The company's innovations significantly reduce the time required for police to examine consumer devices, thereby enhancing the efficiency of investigations.

EnteroBiotix Limited is a biotechnology company based in Edinburgh, United Kingdom, founded in 2017. It specializes in the research, development, and commercialization of orally available products for fecal microbiota transplantation. By utilizing bacterial communities derived from the human gastrointestinal tract, EnteroBiotix aims to restore health and prevent bacterial infections. The company focuses on creating microbial therapeutics, both allogenic and autologous, designed to address serious unmet medical needs. Its product pipeline includes high-diversity microbiome-modulating drugs tailored to fortify and restore the microbiome, enabling physicians to effectively prevent and treat various debilitating infections and diseases.

Talking Medicines Limited is a data technology company based in Glasgow, United Kingdom, that focuses on capturing and structuring the global voice of patients regarding launched medicines. The company offers Medsmart, an application that collects comprehensive data about medication adherence, including how, why, and what patients are taking. Its services include PatientMetRx®, a social intelligence platform that employs artificial intelligence and natural language processing to transform unstructured feedback from patients into actionable insights for pharmaceutical companies. This platform allows clients to utilize large language models to access curated patient and healthcare professional experiences, thereby enabling data-driven decision-making. Talking Medicines also provides a real-world persona data service with monthly updates, digital focus groups for surveys and questionnaires, and custom solutions tailored to specific pharmaceutical needs. Established in 2013 and rebranded in December 2015, the company serves the pharmaceutical and healthcare sectors, aiming to enhance marketing effectiveness and improve patient health outcomes through advanced patient insights.